TTRX 8-K 2026-11-10

Turn Therapeutics Inc. (TTRX) 8-K dated 2026-11-10 — accession 0001213900-26-117781.

Turn Therapeutics Inc. (TTRX) is a biotechnology company listed on NASDAQ.

Turn Therapeutics Inc. filed a 8-K on 2026-11-10. Accession 0001213900-26-117781.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for TTRX is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The TTRX SEC hub lists recent forms. The stock page is the research view.